MEDIA
The shareholders of Pharma Way AB (559146-3400)
Summoned to Annual General Meeting
Thursday 23 June 2024 at 14.00
at Quick Office Mälarhöjdens office hotel, Västertorpsvägen 135 in Hägersten, Sweden.
Right to attend the meeting, etc.
Shareholders who wish to participate in the general meeting must be entered in the share register no later than on the day of the meeting. A shareholder who is not present in person at the meeting may exercise his or her right at the meeting through a proxy with an original signed and dated power of attorney signed and dated by the shareholder. The power of attorney must not be older than one year. A shareholder or proxy may bring a maximum of two assistants to the meeting.
Shareholders are requested to notify their participation, no later than 17 May 2024, to the company at Pharma Way AB, c/o Mårten Österlund, Långängsvägen 24, 125 56 Älvsjö or by e-mail: marten.osterlund@pharma-way.com. The notification must state name, address, telephone number, personal or corporate identity number and shareholding and, where applicable, information about proxies or assistants.
Draft agenda
1. Opening of the meeting and election of chairman of the meeting
2. Preparation and approval of the voting list
3. Election of one or two persons to verify the minutes
4. Determination of whether the meeting has been duly convened
5. Approval of the agenda
6. Presentation of the presented annual report and auditor's report and, where applicable, the consolidated financial statements and the auditor's report on the consolidated accounts
7. Resolutions: (a) on adoption of the income statement and balance sheet and, where applicable, the consolidated income statement and consolidated balance sheet; (b) on the appropriation of the company's profit or loss in accordance with the adopted balance sheet; c) Discharging the members of the Board of Directors and the CEO from liability
8. Determination of the number of Board members and deputy Board members as well as auditors and deputy auditors
9. Determination of fees for the members of the Board of Directors and auditors
10. Election of the Board of Directors and auditors as well as any deputy members of the Board of Directors and deputy auditors
11. Resolution authorizing the Board of Directors to resolve on a new issue of shares
12. Resolution authorizing the Board of Directors to make minor adjustments to resolutions made at the Annual General Meeting in connection with registration with the Swedish Companies Registration Office
13. End of the meeting
The Board of Directors' proposal for resolution
Item 7 b) – Resolution on the appropriation of the company's profit or loss according to the adopted balance sheet
The Board of Directors proposes to the Annual General Meeting that the company's earnings be disposed of in accordance with the Board's proposals in the annual report. The Board of Directors does not propose any dividend.
Item 11 – Resolution authorizing the Board of Directors to resolve on a new issue of shares
The Board of Directors proposes that the Annual General Meeting authorize the Board of Directors, on one or more occasions before the next Annual General Meeting, with or without deviation from the shareholders' preferential rights, to resolve on a new issue of shares within the limits of the Articles of Association. Payment may be made in cash, by set-off, contribution of consideration other than in cash or, in other cases, with conditions in accordance with Chapter 2, Section 5, second paragraph, 1-3 and 5 of the Swedish Companies Act. New share issues in accordance with this authorization shall be made on market terms. The purpose of the authorization and the reasons for deviation from the shareholders' preferential rights is to give the Board flexibility in its work to finance and enable continued expansion.
Item 12 – Proposal for a decision authorising minor adjustments
The meeting is proposed to authorize the board of directors or the person appointed by the board to make minor adjustments to the resolutions made at the meeting in the event that the need arises when registering with the Swedish Companies Registration Office.
Information and documents, etc.
For a valid resolution pursuant to item 11, the resolution must be supported by shareholders representing at least two-thirds of both the votes cast and the shares represented at the meeting.
Shareholders are reminded of their right under Chapter 7. Section 32 of the Swedish Companies Act to request information from the Board of Directors at the general meeting about circumstances that may affect the assessment of an item on the agenda or the assessment of the company's financial situation.
The annual report and auditor's report will be made available at Långängsvägen 24 in Älvsjö, no later than three weeks before the meeting, and thereafter sent to shareholders who so request and provide their postal address.
__________________
Stockholm, April 24th 2024
Pharma Way AB
Board